Evaluation of Osteoblast Responses to Silver-Hydroxyapatite/Titania Nanoparticles In Vitro


Article Preview

In the present in vitro study, osteoblasts proliferation, vitality and ultrastructure were investigated when cultured in the presence of silver-hydroxyapatite/titania nanoparticles (nAg_HA/TiO2) compared to HA nanoparticles (nHA) at various concentrations and cell culture without nanoparticles for up to 120 hours. Results confirmed the detrimental influences of both nAg_HA/TiO2 and nHA on osteoblast growth.Cell vitality was slightly higher during the earlier 24h, but after that was inhibited. Both cell proliferation and vitality by addition of nanoparticles were restricted with concentrations of nanoparticles increasing. However, the respiration rates by addition of nanoparticles were showed higher than that of the cell culture without nanoparticles. No remarkable ultrastructure changes were showed in the osteoblasts exposed nanoparticles. The difference in cell proliferation, vitality and ultrastructure between nAg_HA/TiO2 and nHA were insignificant. It was demonstrated that biocompatibility of nAg_HA/TiO2 is almost the same as nHA.



Key Engineering Materials (Volumes 330-332)

Main Theme:

Edited by:

Xingdong Zhang, Xudong Li, Hongsong Fan, Xuanyong Liu




J. C. Zhang et al., "Evaluation of Osteoblast Responses to Silver-Hydroxyapatite/Titania Nanoparticles In Vitro", Key Engineering Materials, Vols. 330-332, pp. 447-450, 2007

Online since:

February 2007




[1] A Gristina: Clin Orthop Relat Res. Vol. 427 (2004), p.4.

[2] Nishioka M, Nishimura T, Okubo A and Taya M: Biotechnology Letters. Vol. 25 (2003), p.1263.

[3] Suketa N, Sawase T, Kitaura H, et al. Clin Implant Dent Relat Res. Vol. 7(2005), p.105.

[4] Tsuji H, Sugahara H and Gotoh Y: Nucl Ins Metho in Phys Res Sec B. Vol. 206 (2003), p.249.

[5] Fukuchi N, Akao M and Sato A: Biomed Mater Eng. Vol. 5(1995), 219.

[6] Gutwein LG and Webster TJ: Biomaterials. Vol. 25(2004), p.4175.

[7] Williams RL, Doherty PJ, Vince DG, et al. Crit Rev Biocompat. Vol. 5 (1989), p.221.

[8] Modak SM and Fox Jr CL: Biochem Pharmacol. Vol. 22 (1973), p.2391.

[9] Aoki H, Science and Medical Application of Hydroxyapatite, (JAAS, Tokayama Press System Centre Co., Inc., 1991), p.21. a b c.